Quirin Hammer
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- Reproductive System and Pregnancy
- Immunotherapy and Immune Responses
- Immune responses and vaccinations
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Immunology 24
- Immune Cell Function and Interaction 24
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 5
- IL-33, ST2, and ILC Pathways 3
- Oncology 12
- CAR-T cell therapy research 12
- Co-authors
- Chiara Romagnani (10 shared papers)Timo Rückert (3 shared papers)Merlin V. Luetke-Eversloh (2 shared papers)Michelle Sætersmoen (3 shared papers)Bahram Valamehr (5 shared papers)Dan S. Kaufman (1 shared paper)Karl‐Johan Malmberg (8 shared papers)Pawel Durek (2 shared papers)
In The Last Decade
Quirin Hammer
23 papers receiving 998 citations
Peers
Comparison fields: 5 of 74
- Immunology 812
- Oncology 307
- Virology 40
- Hematology 66
- Epidemiology 183
Countries citing papers authored by Quirin Hammer
This map shows the geographic impact of Quirin Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quirin Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quirin Hammer more than expected).
Fields of papers citing papers by Quirin Hammer
This network shows the impact of papers produced by Quirin Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quirin Hammer. The network helps show where Quirin Hammer may publish in the future.
Co-authors
The 25 scholars most cited alongside Quirin Hammer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 208 | |
| 2 | 2016 | 176 | |
| 3 | 2018 | 172 | |
| 4 | 2018 | 117 | |
| 5 | 2016 | 62 | |
| 6 | 2016 | 60 | |
| 7 | 2024 | 38 | |
| 8 | 2018 | 36 | |
| 9 | 2020 | 24 | |
| 10 | 2024 | 23 | |
| 11 | 2021 | 18 | |
| 12 | 2018 | 17 | |
| 13 | 2017 | 14 | |
| 14 | 2024 | 10 | |
| 15 | 2023 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2022 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2021 | 3 |
About Quirin Hammer
Quirin Hammer is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Hematology, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (24 papers), CAR-T cell therapy research (12 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (5 papers), Cytomegalovirus and herpesvirus research (4 papers), IL-33, ST2, and ILC Pathways (3 papers), RNA Interference and Gene Delivery (2 papers) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Immunology (812 citations), Oncology (307 citations), Virology (40 citations), Hematology (66 citations) and Epidemiology (183 citations). Quirin Hammer has collaborated with scholars based in Sweden, Norway and Germany. Frequent co-authors include Chiara Romagnani, Timo Rückert, Merlin V. Luetke-Eversloh, Michelle Sætersmoen, Bahram Valamehr, Dan S. Kaufman, Karl‐Johan Malmberg, Pawel Durek, Gilles Gasparoni and Hyun‐Dong Chang. Their work appears in journals such as Blood, European Journal of Immunology, PLoS Pathogens, Med and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.